Shannon P. Hilchey

Increased rejection of primary tumors in mice lacking B cells: Inhibition of anti-tumor CTL and TH1 cytokine responses by B cells

Anagha Divekar, Shannon P. Hilchey, Hyun-Mi Cho et al. · International Journal of Cancer · 2005 · 224 citations · Full text

Life Sciences, Immunology, Oncology +17

Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a “vaccinal effect” of rituximab

Shannon P. Hilchey, Ollivier Hyrien, Tim R. Mosmann et al. · Blood · 2009 · 153 citations · Full text

Life Sciences, Immunology, Oncology +16

The mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivatives

Steven H. Bernstein, Sundararajan Venkatesh, Min Li et al. · Blood · 2012 · 139 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Follicular Lymphoma Intratumoral CD4+CD25+GITR+ Regulatory T Cells Potently Suppress CD3/CD28-Costimulated Autologous and Allogeneic CD8+CD25− and CD4+CD25− T Cells

Shannon P. Hilchey, Asit K. De, Lisa M. Rimsza et al. · The Journal of Immunology · 2007 · 84 citations

Life Sciences, Immunology, Oncology +17

Human Follicular Lymphoma CD39+-Infiltrating T Cells Contribute to Adenosine-Mediated T Cell Hyporesponsiveness

Shannon P. Hilchey, James J. Kobie, Mathew R. Cochran et al. · The Journal of Immunology · 2009 · 78 citations · Full text

Life Sciences, Immunology, Pharmacology +17